vision loss with tirzepatide and Macular Degeneration: Current Evidence and Monitoring Scientists Explain 'Ozempic Blindness,' Link
Description
Access to tirzepatide (Mounjaro) through primary care is not expected to start in mid and south Essex until later in 2025

Kramer CM, Borlaug BA, Zile MR, Ruff D, DiMaria JM, Menon V, et al

Consult with your healthcare provider if progress stalls for more than four weeks

Sometimes dramatically
Mounjaro is more costly but more effective than Ozempic in controlling blood sugar levels and weight loss but may have additional side effects

NA, not applicable